In this edition of Device Week, Catherine Longworth reports on eye-care giant Alcon's $28bn spin-off from Novartis. Marion Webb reviews her interview with executives from EOS imaging SA, a developer of imaging medical devices for orthopedics.

Medtech Insight articles addressing topics discussed in this episode:

All 'Bye' Itself: Alcon Spins Out From Novartis In $25Bn Stock Listing
https://bit.ly/2G4qLhX

Adios To Alcon In April As Novartis Confirms Spin-Off Date
https://bit.ly/2Z1xbXA

The Many Layers Of EOS Imaging – Surgical Planning, Low-Dose Imaging, 3D Services
https://bit.ly/2Gf8lwd